"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 1 | 6 |
| 1996 | 6 | 8 | 14 |
| 1997 | 2 | 5 | 7 |
| 1998 | 3 | 9 | 12 |
| 1999 | 5 | 8 | 13 |
| 2000 | 2 | 6 | 8 |
| 2001 | 5 | 7 | 12 |
| 2002 | 5 | 13 | 18 |
| 2003 | 6 | 9 | 15 |
| 2004 | 3 | 9 | 12 |
| 2005 | 6 | 10 | 16 |
| 2006 | 5 | 3 | 8 |
| 2007 | 1 | 6 | 7 |
| 2008 | 6 | 12 | 18 |
| 2009 | 5 | 9 | 14 |
| 2010 | 2 | 7 | 9 |
| 2011 | 6 | 12 | 18 |
| 2012 | 10 | 12 | 22 |
| 2013 | 14 | 7 | 21 |
| 2014 | 12 | 12 | 24 |
| 2015 | 21 | 11 | 32 |
| 2016 | 12 | 17 | 29 |
| 2017 | 13 | 14 | 27 |
| 2018 | 19 | 13 | 32 |
| 2019 | 13 | 11 | 24 |
| 2020 | 24 | 16 | 40 |
| 2021 | 25 | 31 | 56 |
| 2022 | 4 | 52 | 56 |
| 2023 | 5 | 43 | 48 |
| 2024 | 26 | 13 | 39 |
| 2025 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 Feb 05; 80(1):223-227.
-
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. J Infect Dis. 2025 Feb 04; 231(1):e123-e131.
-
Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S27-S31.
-
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost. Nat Commun. 2025 Jan 17; 16(1):759.
-
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59?. Vaccine. 2025 Feb 15; 47:126702.
-
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens. Vaccine. 2025 Feb 15; 47:126689.
-
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance. PLoS One. 2024; 19(12):e0306953.
-
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization. Front Immunol. 2024; 15:1480976.
-
Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Dec 16; 230(6):1376-1379.
-
Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative, prospective, observational cohort study. Lancet Microbe. 2025 Feb; 6(2):100935.